School of Medical Science and Technology

• FRSB
• J C Bose National Fellow
• FNA
• FNSc
• FNASc

Journal
• ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors Biswas A., Rajesh Y. , Mitra P. , Mandal M. By BBA - Reviews on Cancer - (Accepted/In-Press)
• Glycopolymer Decorated pH-Dependent Ratiometric Fluorescent Probe Based on Förster Resonance Energy Transfer for the Detection of Cancer Cells Bhattacharya K., Kundu M. , Das S. , Samanta S. , Roy S. S., Mandal M. , Singha N. K. By Macromol. Rapid Communication 44 2200594- (2023)
• Nitrogen and sulphur doped carbon dot: An excellent biocompatible candidate for in-vitro cancer cell imaging and beyond Ghosh T., Nandi S. , Bhattacharya S. K., Ghosh S. K., Mandal M. , Banerji P. , Das N. C. By Environmental Research 217 114922- (2023)
• Surfactin-like lipopeptides from Bacillus clausii efficiently bind to spike glycoprotein of SARS-CoV-2 Baindara P., Chowdhury T., Roy D., Mandal M., Mandal S.M. By Journal of Biomolecular Structure and Dynamics - (2023)
• Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo- and radioresistances Kola P., Nagesh P.K.B., Roy P.K., Deepak K., Reis R.L., Kundu S.C., Mandal M. By Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology - (2023)
• Quantitative structural assessments of potential meprin inhibitors by non-linear QSAR approaches and validation by binding mode of interaction analysis Banerjee S., Baidya S.K., Ghosh B., Nandi S., Mandal M., Jha T., Adhikari N. By New Journal of Chemistry 47 7051-7069 (2023)
• Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway Pradhan R., Paul S., Das B., Sinha S., Dash S.R., Mandal M., Kundu C.N. By Journal of Nutritional Biochemistry 113 - (2023)
• Magnolol induces cytotoxic autophagy in glioma by inhibiting PI3K/AKT/mTOR signaling Kundu M., Das S., Das C.K., Kulkarni G., Das S., Dhara D., Mandal M. By Experimental Cell Research 424 - (2023)
• Fruity-scented antifungal volatiles from endophytic Geotrichum candidum PF005: Broad-spectrum bioactivity against stored grain pathogens, mode of action and suitable formulation for mycofumigation Mitra M., Venkatesh P. , Ghissing U. , Biswas A. , Mitra A. , Mandal M. , Mishra H. N., Maiti M. K. By Biological Control 177 - (2023)
• A novel computational predictive biological approach distinguishes Integrin 1 as a salient biomarker for breast cancer chemoresistance Das S., Kundu M., Hassan A., Parekh A., Jena B.C., Mundre S., Banerjee I., Yetirajam R., Das C.K., Pradhan A.K., Das S.K., Emdad L., Mitra P., Fisher P.B., Mandal M. By Biochimica et Biophysica Acta - Molecular Basis of Disease 1869 - (2023)
• A computational study to assess the polymorphic landscape of matrix metalloproteinase 3 promoter and its effects on transcriptional activity Banik P., Majumder R., Mandal A., Dey S., Mandal M. By Computers in Biology and Medicine 145 - (2022)
• TGF- 1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation Jena B.C., Das C.K., Banerjee I., Bharadwaj D., Majumder R., Das S., Biswas A., Kundu M., Roy P.K., Kundu C.N., Mandal M. By Experimental Cell Research 417 - (2022)
• Screening of the Prime bioactive compounds from Aloe vera as potential anti-proliferative agents targeting DNA Majumder R., Das C.K., Banerjee I., Chandra Jena B., Mandal A., Das P., Pradhan A.K., Das S., Basak P., Das S.K., Emdad L., Fisher P.B., Mandal M. By Computers in Biology and Medicine 141 - (2022)
• A two-photon responsive hydroxyphenylquinazolinone (HPQ)-based fluorescent organic nanoprodrug for H2S release against oxidative stress Chaudhuri A., Singha T. , Jena B. C., Shee M. , Datta P. K., Mandal M. , Pradeep N. D. By Chemical Communications 59 1177-1180 (2022)
• Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma Biswas A., Rajesh Y. , Das S. , Banerjee I. , Kapoor N. , Mitra P. , Mandal M. By Cancer Letters 544 215811-215825 (2022)
• Gold Nanoparticle Embedded Stimuli-Responsive Functional Glycopolymer: A Potential Material for Synergistic Chemo-Photodynamic Therapy of Cancer Cells Bhattacharya K., Das S., Kundu M., Singh S., Kalita U., Mandal M., Singha N.K. By Macromolecular Bioscience 22 - (2022)
• Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma Mandal M., Banerjee I., Mandal M. By Colloids and Surfaces B: Biointerfaces 220 - (2022)
• Size dependent regeneration capacity of functionalized Capra ear-derived micro-tissue scaffolds for treatment of cartilage defects Maity P.P., Poddar P., Das S., Dixit K., Dhara D., Mandal M., Chowdhury A.R., Dhara S., Mukherjee S. By Materialia 26 - (2022)
• Progressing Towards a Human-Centric Approach in Cancer Research Parekh A., Das S., Das C.K., Mandal M. By Frontiers in Oncology 12 - (2022)
• An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies Roy P.K., Biswas A., Deepak K., Mandal M. By Biochimica et Biophysica Acta - Reviews on Cancer 1877 - (2022)
• Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer Dey A., Kundu M., Das S., Jena B.C., Mandal M. By Biochimica et Biophysica Acta - Reviews on Cancer 1877 - (2022)
• An overview of kinin mediated events in cancer progression and therapeutic applications Deepak K., Roy P.K., Kola P., Mukherjee B., Mandal M. By Biochimica et Biophysica Acta - Reviews on Cancer 1877 - (2022)
• Fabrication of a Vitamin B12-Loaded Carbon Dot/Mixed-Ligand Metal Organic Framework Encapsulated within the Gelatin Microsphere for pH Sensing and In Vitro Wound Healing Assessment Bhattacharya S. K., Nandi S. , Dey T. , Ray S. K., Mandal M. , Das N. C., Banerjee S. By ACS Applied Bio Materials 5 5693 57- (2022)
• Comparative Study of Nitro and Azide Functionalized ZnII Based Coordination Polymers (CPs) as Fluorescent Turn On Probes for Rapid and Selective Detection of H2S in Living Cells Saha S., Roy P. K., Maity K. , Mandal M. , Biradha K. By Chemistry-A European Journal 28 - (2022)
• Comparative Study of Nitro- and Azide-Functionalized ZnII-Based Coordination Polymers (CPs) as Fluorescent Turn-On Probes for Rapid and Selective Detection of H2S in Living Cells Saha S., Roy P.K., Maity K., Mandal M., Biradha K. By Chemistry - A European Journal 28 - (2022)
• Paracrine TGF- 1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway Chandra Jena B., Kanta Das C., Banerjee I., Das S., Bharadwaj D., Majumder R., Mandal M. By Biochemical Pharmacology 186 - (2021)
• Paracrine TGF- 1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway Jena B. C., Das C. K., Banerjee I. , Das S. , Bharadwa D. , Majumder R. , Mandal M. By Biochem Pharmacol. Feb 16;186: - (2021)
• Ground-State Proton-Transfer (GSPT)-Assisted Enhanced Two-Photon Uncaging from a Binol-based AIE-Fluorogenic Phototrigger Roy B., Roy S., Kundu M., Maji S., Pal B., Mandal M., Singh N.D.P. By Organic Letters - (2021)
• Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages Pradhan R., Chatterjee S., Hembram K.C., Sethy C., Mandal M., Kundu C.N. By Journal of Nutritional Biochemistry 92 - (2021)
• Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response Jena B.C., Rout L., Dey A., Mandal M. By Journal of Cellular Physiology - (2021)
• Natural products based nanoformulations for cancer treatment: Current evolution in Indian research. Kundu M., Majumder R. , Das C. K., Mandal M. By Biomed Mater. - (2021)
• Ag NPs incorporated Self-healable Thermoresponsive Hydrogel Using Precise Structural Interlocking Complex of Polylectrolyte BCPs: A Potential New Wound Healing Material Banerjee S. L., Bhattacharyya K. , Das S. , Kundu M. , Mandal M. , Singha N. K. By Chemical Engineering Journal 405 126436- (2021)
• Synthesis, self-assembly and drug release study of a new dual-responsive biocompatible block copolymer containing phenylalanine derivative Biswas G., Jena B.C., Samanta P., Mandal M., Dhara D. By Journal of Macromolecular Science, Part A: Pure and Applied Chemistry 58 792-803 (2021)
• Sericin-chitosan-glycosaminoglycans hydrogels incorporated with growth factors for in vitro and in vivo skin repair. Sapru S., Das S. , Mandal M. , Ghosh A. K., Kundu S. C. By Carbohydr Polym. 258 117717- (2021)
• The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction Jena B.C., Mandal M. By Biochimica et Biophysica Acta - Reviews on Cancer 1875 - (2021)
• Therapeutic targeting of membrane-associated proteins in central nervous system tumors Roy P.K., Rajesh Y., Mandal M. By Experimental Cell Research 406 - (2021)
• Glycopolymer Ornamented Octa-arm POSS Based Organic-Inorganic Hybrid Star Block Copolymer as a Lectin Binding Ligand Bhattacharya K., Banerjee S. L., Kundu M. , Singha N. K., Mandal M. By Materials Science & Engineering C 116 111210- (2020)
• Acoustic cavitation assisted destratified clay tactoid reinforced in situ elastomer-mimetic semi-IPN hydrogel for catalytic and bactericidal application Ganguly S., Das P. , Das T. K., Ghosh S. , Das S. , Bose M. , Mandal M. , Das A. K., Das N. C. By Ultrasonics Sonochemistry 60 104797- (2020)
• In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M pro) from flavonoid based phytochemical constituents of Calendula officinalis. Das P., Majumder R. , Mandal M. , Basak P. By J Biomol Struct Dyn. Jul 24:1-16. 2396-2417 (2020)
• ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors Biswas A., Rajesh Y. , Mitra P. , Mandal M. By Biochimica et Biophysica Acta - Reviews on Cancer 1874 188389- (2020)
• Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma Rajesh Y., Biswas A., Banik P., Pal I., Das S., Borkar S.A., Sardana H., Saha A., Das S.K., Emdad L., Fisher P.B., Mandal M. By Oncotarget 11 1097-1108 (2020)
• A two-photon responsive naphthyl tagged p-hydroxyphenacyl based drug delivery system: uncaging of anti-cancer drug in the phototherapeutic window with real-time monitoring Singh A. K., Kundu M. , Roy S. , Roy B. , Shah S. , Nair A. , Pal B. , Mandal M. , Pradeep N. D. By Chem. Commun. 56 9986-9989 (2020)
• Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma Rajesh Y., Biswas A., Kumar U., Banerjee I., Das S., Maji S., Das S.K., Emdad L., Cavenee W.K., Mandal M., Fisher P.B. By Proceedings of the National Academy of Sciences of the United States of America 117 12324-12331 (2020)
• Curcumin complexed with graphene derivative for breast cancer therapy De D., Das C. K., Mandal D. , Mandal M. , Pawar N. , Chandra A. , Gupta A. N. By ACS Applied Bio Materials 3 6284-6296 (2020)
• Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach Majumder R., Mandal M. By J Biomol Struct Dyn 1-16 (2020)
• Fluidic embedding of additional macroporosity in alginate-gelatin composite structure for biomimetic application Banerjee A., Das S. , Mandal M. , Ganguly S. By Journal of Biomaterials Science Polymer Edition - (2020)
• Senescence in Polyploid Giant Cancer Cells: A Road That Leads to Chemoresistance. 3. Bharadwaj D., Mandal M. By Cytokine Growth Factor Rev 52 68-75 (2020)
• Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression Jena B.C., Das C.K., Bharadwaj D., Mandal M. By Biochimica et Biophysica Acta - Reviews on Cancer 1874 - (2020)
• Lead bioactive compounds of Aloe vera as potential anticancer agent Majumder R., Das C.K., Mandal M. By Pharmacological Research 148 - (2019)
• ual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer Sen K., Banerjee S. , Mandal M. By Colloids Surf B Biointerfaces Aug 1;180: 9-22 (2019)
• N-doped carbon dot as fluorescent probe for detection of cysteamine and multicolor cell imaging Konar S., Kumar B.N.P., Mahto M.K., Samanta D., Shaik M.A.S., Shaw M., Mandal M., Pathak A. By Sensors and Actuators, B: Chemical 286 77-85 (2019)
• Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management Rajesh Y., Banerjee A. , Pal I. , Biswas A. , Das S. , Dey K. K., Kapoor N. , Ghosh A. K., Mitra P. , Mandal M. By Biochimica et Biophysica Acta - General Subjects 1863 1196-1209 (2019)
• Nonmulberry silk protein sericin blend hydrogels for skin tissue regeneration - in vitro and in vivo Sapru S., Das S., Mandal M., Ghosh A.K., Kundu S.C. By International Journal of Biological Macromolecules 137 545-553 (2019)
• A copper-free click reaction for the synthesis of redox-responsive water-soluble core cross-linked nanoparticles for drug delivery in cancer therapy Biswas G., Jena B.C., Sahoo S., Samanta P., Mandal M., Dhara D. By Green Chemistry 21 5624-5638 (2019)
• A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model Banerjee I., De M., Dey G., Bharti R., Chattopadhyay S., Ali N., Chakrabarti P., Reis R.L., Kundu S.C., Mandal M. By Biomaterials Science 7 1161-1178 (2019)
• Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin- -catenin-vinculin axis. Pal I., Rajesh Y. , Banik P. , Dey G. , Dey K. K., Bharti R. , Naskar D. , Chakraborty S. , Ghosh S. K., Das S. K., Emdad L. , Kundu S. C., Fisher P. B., Mandal M. By Cancer Letters 252 254-263 (2019)
• Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma. Rajesh Y., A B. , U K. , S D. , Banerjee I. , Banik P. , Bharti R. , Nayak S. , Ghosh S. K., Mandal M. By Biochem Pharmacology 164 1-16 (2019)
• Prospect of natural products in glioma: A novel avenue in glioma management Kundu M., Das S., Dhara D., Mandal M. By Phytotherapy Research 33 2571-2584 (2019)
• Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer Das C.K., Banerjee I., Mandal M. By Seminars in Cancer Biology - (2019)
• Push-Pull Stilbene: Visible Light Activated Photoremovable Protecting Group for Alcohols and Carboxylic Acids with Fluorescence Reporting Employed for Drug Delivery Paul A., Biswas A., Sinha S., Shah S.S., Bera M., Mandal M., Singh N.D.P. By Organic Letters 21 2968-2972 (2019)
• Microwave assisted green synthesis of Zwitterionic photolumenescent N-doped carbon dots: an efficient on-off chemosensor for tracer Cr (+ 6) considering the inner filter effect and nano drug-delivery vector Ganguly S., Das P. , Das S. , Ghorai U. , Bose M. , Ghosh S. , Mandal M. , Das A. K., Banerjee S. , Das N. C. By Colloids and Surfaces A: Physicochemical and Engineering Aspects 579 123604- (2019)
• Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer Sen K., Banerjee S., Mandal M. By Colloids and Surfaces B: Biointerfaces 180 9-22 (2019)
• Real-time monitoring of a photoactivated hydrogen persulfide donor for biological entities Chaudhuri A., Venkatesh Y., Jena B.C., Behara K.K., Mandal M., Singh N.D.P. By Organic and Biomolecular Chemistry 17 8800-8805 (2019)
• Real-time monitoring of photo-activated hydrogen persulfide donor for biological entities Pradeep N. D., Chaudhuri A. , Yarra . , Jena . , Behara . , Mandal M. By Org. Biomol. Chem - (2019)
• Osteochondral Defects Healing Using Extracellular Matrix Mimetic Phosphate/Sulfate Decorated GAGs-Agarose Gel and Quantitative Micro-CT Evaluation Kapat K., Rameshbabu A.P., Maity P.P., Mandal A., Bankoti K., Dutta J., Das D.K., Dey G., Mandal M., Dhara S. By ACS Biomaterials Science and Engineering 5 149-164 (2019)
• REDOX Responsive Fluorescence Active Glycopolymer Based Nanogel: A Potential Material for Targeted Anticancer Drug Delivery Bhattacharya K., Banerjee S.L., Das S., Samanta S., Mandal M., Singha N.K. By ACS Applied Bio Materials 2 2587-2599 (2019)
• Stepwise dual stimuli triggered dual drug release by a single naphthalene based two-photon chromophore to reverse MDR for alkylating agents with dual surveillance in uncaging steps Roy B., Kundu M., Singh A.K., Singha T., Bhattacharya S., Datta P.K., Mandal M., Singh N.D.P. By Chemical Communications 55 13140-13143 (2019)
• Stepwise dual stimuli triggered dual drug release by a single naphthalene based two-photon chromophore to reverse MDR for alkylating agents with dual surveillance in uncaging steps Pradeep N. D., Roy B. , Kundu M. , Singh A. K., Singha T. , Bhattacharya S. , Datta P. K., Mandal M. By Chem. Commun 55 13140-13143 (2019)
• Existence of Carbon Nanodots in Human Blood. Mandal S. M., Sinha T. K., Katiyar A. K., Das S. , Mandal M. , Ghosh S. By J Nanosci Nanotechnol Nov 1;19(11) 6961-6964 (2019)
• Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers Das C.K., Jena B.C., Banerjee I., Das S., Parekh A., Bhutia S.K., Mandal M. By Molecular Pharmaceutics 16 24-40 (2019)
• Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer. Das C. K., Parekh A. , Parida P. K., Bhutia S. K., Mandal M. By Biochim Biophys Acta Mol Cell Res. 1866(6) 1004-1018 (2019)
• Selective and sensitive detection of cinnamaldehyde by nitrogen and sulphur co-doped carbon dots: a detailed systematic study Konar S., Samanta D. , Mandal S. , Das S. , Mahto M. K., Shaw M. , Mandal M. , Pathak A. By RSC Advances 8 42361-42373 (2018)
• Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo Das A. K., Parekh A. , Das S. , Parida S. , Das C. K., Dutta D. , Mallick S. K., Wu P. , Kumar B. , Bharti R. , Dey G. , Banerjee K. , Rajput S. , Bharadwaj D. , Pal I. , Dey K. K., Rajesh Y. , Jena B. C., Biswas A. , Banik P. , Pradhan A. K., Das S. K., Dhara S. , Fisher P. B., Wirtz D. , Mills G. B., Mandal M. By Oncogene 37 4546-4561 (2018)
• Selective and sensitive detection of cinnamaldehyde by nitrogen and sulphur co-doped carbon dots: A detailed systematic study Konar S., Samanta D., Mandal S., Das S., Mahto M.K., Shaw M., Mandal M., Pathak A. By RSC Advances 8 42361-42373 (2018)
• Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer Kumar B., Nagaprasad P. , Rajput S. , Sarkar S. , Mahto M. K., Yallapu M. M., Pathak A. , Emdad L. , Das S. ., Reis R. ., Kundu S. C., Fisher P. B., Mandal M. By Molecular Pharmaceutics 15 2698-2713 (2018)
• Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer. Kumar B., Puvvada N. , Rajput S. , Sarkar S. , Mahto M. K., Yallapu M. M., Pathak A. , Emdad L. , Das S. K., Reis R. L., Kundu S. K., Fisher P. B., Mandal M. By Mol Pharm. 15(7) 2698-2713 (2018)
• Jigsaw electrode design for electrowetting devices Sohail S., Jaffery J. A., Biswas K. By Micro & Nano Letters 14 1046-1051 (2018)
• Preferential hepatic uptake of paclitaxel-loaded poly-(D-L-lactide-co-glycolide) nanoparticles â A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution Mandal D., Shaw T.K., Dey G., Pal M.M., Mukherjee B., Bandyopadhyay A.K., Mandal M. By International Journal of Biological Macromolecules 112 818-830 (2018)
• Copper Catalyzed Regioselective N Alkynylation of Pyrazoles and Evaluation of the Anticancer Activity of Ethynyl Pyrazoles Sau M. C., Rajesh Y. , Mandal M. , Bhattacharjee M. By Chemistryselect 3 3511-3515 (2018)
• Copper(II)-sulfonamide Schiff base complexes: Structure, biological activity and theoretical interpretation Mondal S., Mondal T.K., Rajesh Y., Mandal M., Sinha C. By Polyhedron 151 344-354 (2018)
• NIR fluorescent organic nanoparticles for photoinduced nitric oxide delivery with self monitoring and real time reporting ability Pradeep N. D., Behara . , Rajesh Y. , Chaudhuri A. , Gangopadhyay M. , Mandal M. By J. Mater. Chem. B 6 6042-6046 (2018)
• Prospects of nonmulberry silk protein sericin-based nanofibrous matrices for wound healing â In vitro and in vivo investigations Sapru S., Das S., Mandal M., Ghosh A.K., Kundu S.C. By Acta Biomaterialia 78 137-150 (2018)
• Pro-survival autophagy and cancer cell resistance to therapy Das C.K., Mandal M., Kögel D. By Cancer and Metastasis Reviews 37 749-766 (2018)
• Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers. Das C. K., Jena B. C., Banerjee I. , Das S. , Parekh A. , Bhutia S. K., Mandal M. By Mol Pharm - (2018)
• BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells Das C.K., Linder B., Bonn F., Rothweiler F., Dikic I., Michaelis M., Cinatl J., Mandal M., Kögel D. By Neoplasia (United States) 20 263-279 (2018)
• Bioimpedimetric analysis in conjunction with growth dynamics to differentiate aggressiveness of cancer cells. Parekh A., Das D. , Das A. , Dhara S. , Biswas K. , Mandal M. , Das S. By Scientific Reports 8(1): 783- (2018)
• Redox-Responsive Core-Cross-Linked Block Copolymer Micelles for Overcoming Multidrug Resistance in Cancer Cells Maiti C., Parida S. , Kayal S. , Maiti S. , Mandal M. , Dhara D. By ACS Applied Materials and Interfaces 10 5318-5330 (2018)
• Osteochondral Defects Healing Using Extracellular Matrix Mimetic Phosphate/Sulfate Decorated GAGs-Agarose Gel and Quantitative Micro-CT Evaluation Kapat K., Rameshbabu A. P., Maity P. P., Mandal A. , Bankoti K. , Datta J. , Das D. K., Dey G. , Mandal M. , Dhara S. By ACS Biomaterials Science & Engineering 5 149-164 (2018)
• Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer Bharti R., Dey G., Das A.K., Mandal M. By British Journal of Cancer 118 1442-1452 (2018)
• Photoresponsive Block Copolymer Prodrug Nanoparticles as Delivery Vehicle for Single and Dual Anticancer Drugs. Biswas G., Jena B. C., Maiti S. , Samanta P. , Mandal M. , Dhara D. By ACS Omega 2(10) 6677-6690 (2018)
• A dual-analyte probe: hypoxia activated nitric oxide detection with phototriggered drug release ability. Biswas S., Rajesh Y. , Barman S. , Bera M. , Paul A. , Mandal M. , Pradeep N. D. By Chem Commun 54(57) 7940-7943 (2018)
• Wavelength Dependent, Sequentially Activated, Dual Anticancer Drug Delivery System with Photoinduced Fluorescence off-on for Real Time Imaging Pradeep N. D., Mandal M. , Behara . , Rajesh . , Chaudhuri A. , Biswas S. By ChemistrySelect 2017, 2, 4033 2 4033-4038 (2017)
• Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor. Shaw T. K., Mandal D. , Dey G. , Pal M. M., Mandal M. By Drug Delivery 24(1) 346-357 (2017)
• Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition. Rajesh Y., Biswas A. , Mandal M. By Exp Cell Res. 30453-56 (2017)
• Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy Parida S., Maiti C. , Rajesh Y. , Dey K. K., Pal I. , Parekh A. , Patra R. , Dutta P. K., Mandal M. By Biochimica et Biophysica Acta (BBA)-General Subjects 1861 3039-3052 (2017)
• Resensitization of Akt induced Docetaxel resistance in Breast Cancer by Iturin A, a lipopeptide molecule from marine bacterium, Bacillus megaterium. Dey G., Bharti R. , Das A. K., Sen R. , Mandal M. By Scientific reports 7 17324-17335 (2017)
• A self-assembled clavanin A-coated amniotic membrane scaffold for the prevention of biofilm formation by ocular surface fungal pathogens. Mandal S. M., Khan J. , Mandal M. , Franco O. L. By Biofouling 33(10) 881-891 (2017)
• Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions. Banerjee K., Banerjee S. , Mandal M. By J Colloid Interface Sci. 491 98-110 (2017)
• [(para- Cymene) Ru(dppp) Cl] [PF6] - Catalysed Stereospecific Synthesis of O- Dienyl Esters, and Evaluation of the Anticancer Activity of a Long- Chain Fatty Acid O- Dienyl Ester Jena R. K., Rajesh Y. , Mandal M. , Bhattacharjee M. By Eur.J. Org.Chem. 2017(11) 1514-1519 (2017)
• Micellear Gold nanoparticle as delivery vehicle for dual tyrosine kinase inhibitor ZD6474 for metastatic breast cancer treatment. Sarkar S., Konar S. , Puvvada N. , Rajput S. , Kumar P. B., Rao R. R., Pathak A. , Fisher P. B., Mandal M. By Langmuir 33(31): 7649-59 (2017)
• Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment Sarkar S., Konar S. , Nagaprasad, P. , Shashi Rajputl S. , Kumar B. , Rao R. R., Pathak A. , Pathak, Paul B. Fisher, P. B., Mandal M. By Langmuir 33 7649-7659 (2017)
• Therapeutic implication of Iturin A for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion. Cellular Signalling Dey G., Bharti R. , Ojha P. K., Pal I. , R. , Banerjee I. , Banik P. , Parida S. , Parekh A. , Sen R. , Mandal M. By Cellular Signalling 35 24-36 (2017)
• Hydroxyapatite reinforced inherent RGD containing silk fibroin composite scaffolds: promising platform for bone tissue engineering. Behra S., Naskar D. , Sapru S. , Bhattacharjee P. , Dey T. , Ghosh A. K., Mandal M. , Kundu S. C. By Nanomedicine 13 1745-1759 (2017)
• Photoresponsive Block Copolymer Prodrug Nanoparticles as Delivery Vehicle for Single and Dual Anticancer Drugs Biswas G., Jena B. C., Maiti S. , Samanta P. , Mandal M. , Dhara D. By ACS Omega 2 6677-6690 (2017)
• Carbon Nanofiber Reinforced Nonmulberry Silk Protein Fibroin Nanobiocomposite for Tissue Engineering Applications. Naskar D., Bhattacharjee P. , Ghosh A. K., Mandal M. , Kundu S. C. By ACS Appl Mater Interfaces 9(23) 19356-19370 (2017)
• Dual growth factor loaded non-mulberry silk fibroin/carbon nanofiber composite 3D scaffolds for in vitro and in vivo bone regeneration. Naskar D., Ghosh A. K., Mandal M. , Das P. , Nandi S. K., Kundu S. C. By Biomaterials 136 67-85 (2017)
• Cascade photocaging of diazeniumdiolate: A novel strategy for one and two photon triggered uncaging with real time reporting Pradeep N. D., Mandal M. , Behara . , Rajesh Y. , Venkatesh Y. , Pinninti B. By Chem. Commun 53 9470-9473 (2017)
• Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. Bharti R., Dey G. , Banerjee I. , Dey K. K., Parida S. , Kumar B. N., Das C. K., Mandal M. By Cancer Letters 388 292-302 (2017)
• Insights into molecular therapy of glioma: current challenges and next generation blueprint. Rajesh Y., Pal I. , Banik P. , Chakraborty S. , Borkar S. A., Dey G. , Mukherjee A. , Mandal M. By Acta Pharmacol Sin ;38(5): 591-613 (2017)
• Spontaneous Vesicle Formation by gamma-Aminobutyric Acid Derived Steroidal Surfactant:Curcumin Loading, Cytotoxicity and Cellular Uptake Studies Bajani D., Dey J. , Rajesh Y. , Bandyopadhyay S. , Mandal M. By J. Colloid Interface Sci. 507 01-10 (2017)
• Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma. Pal I., Dey K. K., Chaurasia M. , Parida S. , Mandal M. By Tumour Biology 37(5) 6389-6402 (2016)
• Silk fibroin nanoparticles support in vitro sustained antibiotic release and osteogenesis on titanium surface Sharma S., Bano S. , Ghosh A. S., Mandal M. , Kim H. , Dey T. , Kundu S. C. By Nanomedicine: Nanotechnology, Biology, and Medicine 12 1193-1204 (2016)
• Photocaging of Single and Dual (Similar or Different) Carboxylic and Amino Acids by Acetyl Carbazole and its Application as Dual Drug Delivery in Cancer Therapy Pradeep N. D., Mandal M. , Venkatesh Y. , Rajesh Y. , Karthik D. , Chetan A. C., Jana D. By journal of organic chemistry 81 11168-11175 (2016)
• Polymer Grafted Magnetic Nanoparticles for Delivery of Anticancer Drug at Lower pH and Elevated Temperature Dutta S., Parida S. , Maiti C. , Banerje R. , Mandal M. , Dhara D. By Journal of Colloids and Interface Sciences 467 70-80 (2016)
• Pre-clinical Risk Assessment and therapeutic potential of Antitumor Lipopeptide,Iturin A, in in vivo and in vitro Model. Dey G., Bharati R. , Banerjee I. , Sen R. , Mandal M. By RSC Advances 6 71612-71623 (2016)
• Somatostatin receptor targeted liposome with diacerin inhibit IL-6 for breast cancer therapy Bharti R., Dey G. , Banerjee I. , Dey K. K., Parida S. , Kumar P. B., Pal I. , Mukherjee M. , Mishra M. , Pradhan A. K., Emdad L. , Das S. K., Fisher P. B., Mandal M. By Cancer Letters 388 292-302 (2016)
• Sonochemically synthesized biocompatible zirconium phosphate nanoparticles for pH sensitive drug delivery application Kalita H., Kumar B. P., Konar S. , Tantubay S. , Mahto M. K., Mandal M. , Pathak A. By Materials Science and Engg:C (Mater. for Bio. Appl.) 60 84-91 (2016)
• Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer. Bhutia S. K., Behera B. , Mandal M. , Maiti T. K. By Int. J of Cancer 139(2) 457-466 (2016)
• Diacerein mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cance Mandal M. By Oncogene 35(30 3965-75 (2016)
• In Vitro Drug and gene Delivery Using Random Cationic Copolymers Forming Stable and pH-Sensitive Polymersomes Laskar P., Dey J. , Banik P. , Mandal M. , Ghosh S. K. By Macromol. Biosci. 17 1-14 (2016)
• Fe3O4@Zirconium Phosphate Core-shell Fe3O4@Zirconium Phosphate Core-shell Nanoparticles for pH-Sensitive and Magnetically guided Drug Deliver Applications Kalita H., Rajput S. , Kumar B. , Mandal M. , Pathak A. By RSC Advances 6 2016,6,21285-21292 (2016)
• Learning of speckle statistics for in vivo and noninvasive characterization of cutaneous wound regions using laser speckle contrast imaging Basak K., Dey G. , Mahadevappa M. , Mandal M. , Sheet D. , Dutta P. K. By Microvascular Research 107 6-16 (2016)
• Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement. Bharti R., Dey G. , Mandal M. By Cancer Letters 375(1): 51-61 (2016)
• Carbon nanofiber reinforced non-mulberry silk protein fibroin nanobiocomposite for tissue engineering applications Naskar D., Bhattacharjee P. , Ghosh A. K., Mandal M. , Kundu S. By ACS Applied Materials & Interfaces, 9 19356-19370 (2016)
• Gallic acid induced apoptotic events in HCT-15 colon cancer cells. Subramanian A. P., Jaganathan S. K., Mandal M. By World J Gastroenterol 22(15) 3952-3961 (2016)
• GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signalling Parida S., Pal I., Parekh A., Thakur B. Bharti R,. Das S and Mandal M By Cell Death and Disease 24;7:e2154 1-13 (2016)
• Organic Nanoparticle-Based Fluorescent Chemosensor forSelective Switching ON and OFF of Photodynamic Therapy (PDT) Pradeep N. D., Mandal M. , Gangopadhyay M. , Jana D. , Rajesh Y. , Bera M. , Biswas S. , Chowdhury D. , Zhao D. By ChemistrySelect 1 6523-6531 (2016)
• Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy. Banerjee I., De K. , Banerjee D. , Dey G. , Mandal M. By Acta Biomaterial 38 69-81 (2016)
• Three-Arm, Biotin-Tagged Carbazole Dicyanovinyl Chlorambucil Conjugate: Simultaneous Tumor Targeting, Sensing, and Photoresponsive Anticancer Drug Delivery Pradeep N. D., Mandal M. , Venkatesh Y. , Karthik D. , Rajesh Y. , Jana D. By chemistry an asian journal 11 3482-3486 (2016)
• Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes Rajput S., Nagaprasad P. , Kumar B. , Sarkar, S. , Suraj Konar S. , Bharti R. , Dey G. , Mazumdar, A. , Pathak A. , Fisher P. B., Mandal M. By Molecular Pharmaceutics 12 4214-4225 (2015)
• Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes. Rajput S., Puvvada N. , Kumar B. N., Mandal M. By Mol Pharm 4214-4225 (2015)
• Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells. Banerjee K., Mandal M. By Redox Biology 153-162 (2015)
• Marine lipopeptide Iturin A inhibits Akt mediated GSK3 and FoxO3a signaling and triggers apoptosis in breast cancer. Dey G., Bharti R. , Sen R. N., Mandal M. By Scientific Reports - (2015)
• Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity. Dey K. K., Sarkar S. , Pal I. , Mandal M. By Cancer Cell International 15:94 - (2015)
• Diacerein mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer Bharti R., Dey G. , Ojha P. , Rajput S. , Jaganathan S. , Sen R. , Mandal M. By Oncogene 35 3965-3975 (2015)
• Microbial amphiphiles: A class of promising new generation anticancer agents. Dey G., Bharati R. , Sen R. , Mandal M. By Drug Discovery Today 20 (1) 136-146 (2015)
• A targeted, image-guided and dually locked photoresponsive drug delivery system Karthik, S., Kumar B. N., Gangopadhyay M. , Mandal M. , Pradeep N. D. By Journal of Materials Chemistry B 3 (5) 728-732 (2015)
• Probabilistic graphical modeling of speckle statistics in laser speckle contrast imaging for noninvasive and label-free retinal angiography. Basak K., Dey G. , Sheet D. , Mahadevappa M. , Mandal M. , Dutta P. K. By Conf Proc IEEE Eng Med Biol Soc 6244-6247 (2015)
• Probing the potential of apigenin liposomes in enhancing bacterial membrane perturbation and integrity loss. Banerjee K., Banerjee S. , Das S. , Mandal M. By J Colloid Interface Sci. 48-59 (2015)
• Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model. Parida S., Parekh A. , Dey G. , Ghosh S. K., Mandal M. By Cancer Biol Ther 16(6) 922-932 (2015)
• BI2536--A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells. Kumar B. N., Rajput S. , Bharti R. , Parida S. , Mandal M. By Biomed Pharmacother 124-132 (2015)
• Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma. Pal I., Parida S. , Kumar B. N., Banik P. , Mandal M. By Eur J Pharmacol 765 217-227 (2015)
• Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach. Dey K. K., Pal I. , Bharti R. , Dey G. , Mandal M. By Tumor Biology 9827-9829 (2015)
• Thymoquinone restores radiation-induced TGF- expression and abrogates EMT in chemoradiotherapy of breast cancer cells. Rajput S., Kumar B. N., Banik P. , Parida S. , Mandal M. By J of Cellular Physiology 230(3) 620-629 (2015)
• Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression Nagaprasad P., Rajput S. , Kumar B. , Sarkar S. , Konar S. , Brunt K. R., Rao R. R., Mazumdar A. , Das S. K., Basu R. , Fisher P. B., Mandal M. , Pathak A. By Scientific Reports 5 11760-11775 (2015)
• Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression. Puvvada P., Rajput S. , Kumar B. N., Sarkar S. , Mandal M. , Pathak A. By Scientific Reports - (2015)
• Sequential release of drugs from Hollow Manganese Ferrate nanocarriers for Breast cancer therapy Pathak A., Mandal M. , Kumar B. , Nagaprasad P. , Rajput S. , Sarkar S. , Das S. K., Emdad L. , Sarkar D. , Venkatesan P. , Pal I. , Dey G. , Konar S. , Brunt K. R., Rao R. R., Mazumdar A. , Kundu S. C. By J. Mater. Chem. B 12 4214-4225 (2015)
• Wavelet-based multiscale analysis of bioimpedance data measured by electric cell-substrate impedance sensing for classification of cancerous and normal cells. Das D., Shiladitya K. , Biswas K. , Dutta P. K., Parekh A. , Mandal M. , Das S. By Phys Rev E Stat Nonlin Soft Matter Phys. 92(6) - (2015)
• Self-assembled cardanol azo derivatives as antifungal agent with chitin-binding ability. Mahata D., Mandal S. M., Mandal M. , Nag A. , Nando G. B. By Int J Biol Macromol 5-11 (2014)
• Frequency dependent impedimetric cytotoxic evaluation of anticancer drug on breast cancer cell. Pradhan R., Rajput S. , Mandal M. , Mitra A. , Das S. By Biosens Bioelectron 55 44-50 (2014)
• Glucose directly promotes antifungal resistance in the fungal pathogen, Candida spp. Mandal S. M., Mahata D. , Mandal M. , Basak A. By J of Biological Chemistry 289( 37) 25468-73 (2014)
• Identification of multifunctional peptides from human milk. Mandal S. M., Bharti R. , Mandal M. , Ghosh A. K. By Peptides 84-93 (2014)
• Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. Choudhury H., Gorain B. , Dey G. , Mandal M. , Pal T. K. By Int J Pharm. ;460(1-2): 131-143 (2014)
• Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention. Parida S., Mandal M. By Eur J Cancer Prev. 23(5) 432-448 (2014)
• BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24- induced growth inhibition by targeting Akt Pal I, Sarkar S, Rajput S, Dey K, Chakraborty S, Dash R, Das S, Sarkar D, Elisa Barile, Surya De, Pellecchia M, Fisher PB, and Mandal M By British J Cancer 111(1) 101-11 (2014)
• Second generation liposomal cancer therapeutics: transition from laboratory to clinic. Sen K., Mandal M. By Int J Pharm 448(1): 28-43 (2013)
• Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Rajput S., Kumar B. N., Dey K. K., Pal I. , Parekh A. , Mandal M. By Life Science ;93(21) 783-790 (2013)
• Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. Rajput S., Kumar B. N., Sarkar S. , Fisher P. B., Mandal M. By Plos One 8(4) - (2013)
• Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells. Sarkar S., Rajput S. , Tripathi A. K., Mandal M. By Molecular Cancer 12(1): 122-130 (2013)
• Effect of Mangiferin and Mahanimbine on Glucose Utilization in 3T3-L1 cells. Kumar B. D., Krishnakumar K. , Jaganathan S. K., Mandal M. By Pharmacogn Mag. 72-75 (2013)
• Photoresponsive coumarin-tethered multifunctional magnetic nanoparticles for release of anticancer drug. Karthik S., Puvvada N. , Kumar B. N., Rajput S. , Pathak A. , Mandal M. , Singh N. D. By ACS Appl Mater Interfaces. 5(11) 5232-5238 (2013)
• Autophagy: cancer's friend or foe? Bhutia S. K., Mukhopadhyay S. , Maiti T. K., Mandal M. , Fisher P. B. By Adv Cancer Res. 118 61-95 (2013)
• Events associated with apoptotic effect of p-Coumaric acid in HCT-15 colon cancer cells. Jaganathan S. K., Supriyanto E. , Mandal M. By World J Gastroenterol. 19(43) 7726-7732 (2013)
• Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. Kumar B. N., Rajput S. , Dey K. K., Parekh A. , Das S. , Mandal M. By BMC Cancer 13 273- (2013)
• AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells. Venkatesan P., Bhutia S. K., Fisher P. B., Mandal M. By Life Science 789-99 (2012)
• Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. S D., Dey K. K., Dey G. , Pal I. , Kundu S. C., Mandal M. By Plos One - (2012)
• Antitumor promoting potential of selected phytochemicals derived from spices: a review. Rajput S., Mandal M. By Eur J Cancer Prev 21(2) 205-215 (2012)
• Synthesis of biocompatible multicolor luminescent carbon dots for bioimaging applications. Puvvada N., Kumar B. N., Konar S. , Kalita H H. , Mandal M. , Pathak A. By Sci Technol Adv Mater ;13(4) - (2012)
• Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties. Mandal S. M., Migliolo L. , Das S. , Mandal M. By J Cell Biochem. 113(1) 184-193 (2012)
• PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes. Pal I., Mandal M. By Acta Pharmacol Sin 33(12) 1441-58 (2012)
• PKI 166 induced redox signalling and apoptosis through activation of p53, MAP kinase and caspase pathway in epidermoid carcinoma. Das S., Dey K. K., Bharti R. , Maitichoudhury S. , Maiti S. , Mandal M. By J Exp Ther Oncol 10(2) 139-153 (2012)
• Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model. Perumal V., Banerjee S. , Das S. , Sen R. K., Mandal M. By Cancer Nanotechnol. 67-79 (2011)
• The potential of celecoxib-loaded hydroxyapatitechitosan nanocomposite for the treatment of colon cancer Venkatesan P, Puvvada N, Dash R, Kumar BNP, Sarkar D, Azab B, Pathak A, Kundu SC, Fisher PB, Mandal M By Biomaterials 32(15): 3794-3806 (2011)
• nduction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton's lymphoma ascites model. Ramachandran S., Mandal M. By Biomed Pharmacothe 65(7): 461-466 (2011)
• Amino acid based amphiphilic copolymer micelles as carriers of non-steroidal anti-inflammatory drugs: solubilization, in vitro release and biological evaluation. Dutta P., Dey J. , Perumal V. , Mandal M. By Int J Pharm. 407(1-2) 207-216 (2011)
• Engineered silk fibroin protein 3D matrices for in vitro tumor model. Thalukder S., Mandal M. , Kundu S. C. By Biomaterials 32(8) 49-59 (2011)
• ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells. Sarkar S., Mazumdar A. , Dash R. , Sarkar D. , Fisher P. B., Mandal M. By J Cell Physiol. 226(2) 375-384 (2011)
• Antitumor effect of Pleurotus ostreatus derived protein fraction on tumor bearing mice models Maiti S., Mallick S. K., Bhutia S. K., Behera B. , Mandal M. , Maiti T. K. By International Journal Medicinal Mushroom 13 427-440 (2011)
• Apoptotic effect of eugenol in human colon cancer cell lines. Jaganathan S. K., Mazumdar A. , Mondhe D. , Mandal M. By Cell Biol Int. 35(6) 607-615 (2011)
• Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma. Sheti K., Sarkar S. , Mandal M. By J Exp Ther Oncol 9(3) 18793-199 (2011)
• Comparative analyses of different surfactants on matrix-assisted laser desorption/ionization mass spectrometry peptide analysis. Mandal S. M., De S. , Mandal M. , Franco O. L. By Eur J Mass Spectrom (Chichester) 16(5) 567-575 (2010)
• Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis. Jaganathan S. K., Mandal M. By Invest New Drugs ;28(5) 624-633 (2010)
• Marine bacterium derived lipopeptides: Characterization & cytotoxic activity against cancer cell lines Sivapathasekaran C., Das P. , Mukherjee S. , Sarvanakumar J. , Mandal M. , Sen R. By International Journal of Peptide Research & Therapeutics 16 215-222 (2010)
• Studies on the phenolic profiling, anti-oxidant and cytotoxic activity of Indian honey: in vitro evaluation. Jaganathan S. K., Mandal S. M., Jana S. K., Mandal M. By Nat Prod Res. 24(14) 1295-306 (2010)
• Effective bacterial inactivation using low temperature radio frequency plasma. Sureshkumar A., Sankar R. , Mandal M. , Neogi S. By Int J Pharm ;396(1-2) 17-22 (2010)
• Effect of AEE788 and/or Celecoxib on colon cancer cell morphology using advanced microscopic techniques. Venkatesan V., Das S. , Mandal M. By Micron 41(3) 247-256 (2010)
• Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. Jaganathan S. K., Mondhe D. , Mandal M. By J Biomed Biotechnol 989 163- (2010)
• ZD647Cancer Biol Ther4, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. Sarkar S., Mazumdar A. , Dash R. , Sarkar D. , Fisher P. B., Mandal M. By Cancer Biol Ther 9(8 592-603 (2010)
• Biomarkers for the diagnosis of thyroid cancer. Sethi K., Sarkar S. , Das S. , Mohanty B. , Mandal M. By J Exp Ther Oncol 8(4) 341-352 (2010)
• Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer. Sarkar S., Mandal M. By Breast Cancer (Auckl) 17;3 47-60 (2009)
• Antiproliferative effects of honey and of its polyphenols: a review. Jaganathan S. K., Mandal M. By J Biomed Biotechnol. 830616- (2009)
• Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water. Mandal S. M., De S. , Mandal M. By Peptides 30(4) 633-637 (2009)
• Stimulation of indoleacetic acid production in a Rhizobium isolate of Vigna mungo by root nodule phenolic acids. Mandal S. M., Mandal M. , Das A. K., Pati B. R., Ghosh A. K. By Arch Microbio 191(4) 389-393 (2009)
• Iron oxide nanoparticle assisted purification and mass spectrometry based proteolytic mapping of intact CD4+ T cells from human blood. Mandal S. M., Ghosh A. K., Mandal M. By Prep Biochem Biotechnol. 39(1) 20-31 (2009)
• Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma. Kupferman M. E., Mandal M. By J Exp Ther Oncol. 117-127 (2009)
• Proteomics view of a Rhizobium isolate response to arsenite [As(III)] stress. Mandal S. M., Mandal M. , Pati B. R. By Acta Microbiol Immunol Hung 56(2) 157-167 (2009)
• Rapid determination of vitamin B2 and B12 in human urine by isocratic liquid chromatography. Mandal S. M., Mandal M. , Ghosh A. K., De S. By Anal Chim Acta. 640(1) 110-113 (2009)
• Silk sericin protein of tropical tasar silkworm inhibits UVB-induced apoptosis in human skin keratinocytes. Dash R., Mandal M. , Ghosh S. K., Kundu S. C. By Mol Cell Biochem. 311(1-2) 111-119 (2008)
• Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Mandal M., Myers J. N., Al E. By Cancer 112(9) 2088-100 (2008)
• Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinoma. Prichard C. N., Kim S. , Mandal M. , Myers J. N. By Laryngoscope. 117(4) 674-679 (2007)
• Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Kupferman M. E., Mandal M. , Myers J. N. By Oral Oncol 43(5) 440-454 (2007)
• The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. Mandal M., Mills G. B., Myers J. N. By Oral Oncology 42(4) 430-439 (2006)
• Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11. Kim S., Mandal M. , Myers J. N. By Head Neck 28(5) 389-99 (2006)
• Identification and characterization of a sperm motility promoting glycoprotein from buffalo blood serum. Mandal M., Saha S. , Ghosh A. K., Majumder G. C. By J Cell Physiol. 209(2): 353-362 (2006)
• Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788. Kim S., Mandal M. , Myers J. N. By Mol Cancer Ther. ;4(4) 432-40 (2005)
• An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice. Kim S., Mandal M. , Bekele B. N., Myers J. N. By Clin Cancer Res 11(5): 1713-21 (2005)
• Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation. Younis M. N., Mandal M. , Fidler I. J., Myers J. N. By Cancer Research 65(11) 4716-4727 (2005)
• Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Younis M. N., Mandal M. , Mills G. B., Myers J. N. By Mol Cancer Ther 4(8) 1146-1156 (2005)
• Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Schiff B., Mcmurphy A. B., Mandal M. , El-naggar A. K., Myers J. N. By Clin Cancer Res 10(24) 8594-602 (2004)
• Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa). Barnes C. J., Mandal M. , Kumar R. By Mol Cancer Theraphy 2(4) 345-351 (2003)
• MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. Talukde A. H., Mandal M. , Kumar R. By J Biol Chem 278(13) 11676-85 (2003)
• A naturally occurring MTA1 variant sequesters oestrogen receptor-  in the cytoplasm. Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK By Nature 418(6898) 654-657 (2002)
• Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. Berns C. J., Mandal M. , Kumar R. By Cancer Research 62(5) 125-5 (2002)
• Heregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3. Li F., Mandal M. , Kumar R. By FEBS Lett. 524(1-3) 49-53 (2002)
• Heregulin up-regulates heat shock protein-70 expression in breast cancer cells. Mandal M., Li F. , Kumar R. By AniCancer Research 22(4) 1965-9 (2002)
• p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. Li F., Adam L. , Mandal M. , Kumar R. By EMBO Rep. 3(8): 767-73 (2002)
• Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells. Bagheri-yarmand R., Mandal M. By J Biol Chem 276(31) 29403-409 (2001)
• Growth factor regulation of the molecular chaperone calnexin. Li F., Mandal M. , Kumar R. By Biochem Biophys Res Commun 289(3): 725-732 (2001)
• Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. Mandal M., Vadlamudi R. , Mendelsohn J. , Kumar R. By J Biol Chem 276(13) 9699-704 (2001)
• Regulation of elongation factor-1alpha expression by growth factors and anti-receptor blocking antibodies. Talukder A. H., Mandal M. , Mendelsohn J. , Kumar R. By J Biol Chem 276(8) 5636-42 (2001)
• Transcriptional repression of oestrogen receptor by metastasisassociated protein 1 corepressor Mazumdar A, Wang RA, Mishra SK, Adam L, Bagheri-Yarmand R, Mandal M, Vadlamudi RK, Kumar R By Nature Cell Biology 3(1): 30-37 (2001)
• Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Mandal M., Olson D. J., Sharma T. , Vadlamudi R. K., Kumar R. By Gastroenterology 120(1): 71-8 (2001)
• Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells. Mishra S. K., Mandal M. , Mazumdar A. , Kumar R. By FEBS Lett. 507(1) 88-94 (2001)
• Heregulin induces expression, DNA binding activity, and transactivating functions of basic leucine zipper activating transcription factor 4. Talukder A. H., Vadlamudi R. , Mandal M. , Kumar R. By Cancer Research 60(2) 276-81 (2000)
• New insights into anti-HER-2 receptor monoclonal antibody research. Kumar R., Mandal M. , Vadlamudi R. By Semin Oncol. 27(6 Suppl 11) 84-91 (2000)
• Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. Vadlamudi R. K., Adam L. , Wang R. A., Mandal M. , Kumar R. By J Biol Chem 275(46) 36238-44 (2000)
• Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1. Adam L., Vadlamudi R. , Mandal M. , Chernoff J. , Kumar R. By J Biol Chem 275(16): 12041-51 (2000)
• Redistribution of activated caspase-3 to the nucleus during butyric acid-induced apoptosis. Mandal M., Adam L. , Kumar R. By Biochem Biophys Res Commun. ;260(3 775-80 (1999)
• Regulation of cyclooxygenase-2 pathway by HER2 receptor. Vadlamudi R., Mandal M. , Mendelsohn J. , Kumar R. By Oncogene 18(2) 305-14 (1999)
• Regulation of cylooxygenase-2 pathway by HER2 receptor Mandal M, Vadlamudi R Adam L, Steinbach G, Mendelsohn J, Kumar R. By Oncogene 18(2): 305-14 (1999)
• Antisense oligonucleotides to the epidermal growth factor receptor. Witters L., Kumar R. , Mandal M. , Lipton A. By Breast Cancer Res Treat. 53(1) 41-50 (1999)
• Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Mandal M., Bandyopadhyay D. , Goepfert T. M., Kumar R. By Oncogene 16(2) 217-25 (1998)
• Nuclear targeting of Bax during apoptosis in human colorectal cancer cells. Mandal M., Adam L. , Mendelsohn J. , Kumar R. By Oncogene 17(8) 999-1007 (1998)
• Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. Mandal M., Bandyopadhyay D. , Adam L. , Mendelsohn J. , Kumar R. By J Biol Chem 273(3) 1568-73 (1998)
• Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells. Mandal M., Wu X. , Kumar R. By Carcinogenesis 18(1) 229-232 (1997)
• Bcl-2 modulates telomerase activity Mandal M, Kumar R By J Biol Chem 272(22): 14183-14187 (1997)
• Bcl-2 modulates telomerase activity. Mandal M., Kumar R. By J Biol Chem ;272(22 14183-7 (1997)
• NDF induces expression of a novel 46 kD protein in estrogen receptor positive breast cancer cells. Kumar R., Mandal M. By J Cellular Biochemistry 62(1) 102-12 (1996)
• Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells. Kumar R., Mandal M. By Clin Cancer Res 2(7) 1215-1219 (1996)
• Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells Mandal M., Kumar R. By Cell Growth Differ. 7(3) 311-8 (1996)
• Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. Mandal M., Maggirwar S. B., Kumar R. By J Biol Chem 271(48) 30354-9 (1996)
• Cell cycledependent modulation of telemerase activity in tumor cells. Zhu X, Kumar R, Mandal M, Sharma NHW, Dingra U, Sokoloski JA, Hsiao R, Narayanan R. By Proc Natl Acad Sci,USA 93(12) 6091-6095 (1996)
• Stimulation of forward motility of goat cauda epididymal spermatozoa by a serum glycoprotein factor. Mandal M., Banerjee S. , Majumder G. C. By Biol Reproduction 41(6) 993-9 (1989)
Others
• The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF- in CAF mediated tumor progression and therapeutic resistance Chandra Jena B., Sarkar S., Rout L., Mandal M. By Cancer Letters 520 222-232 (2021)
• Senescence in polyploid giant cancer cells: A road that leads to chemoresistance Bharadwaj D., Mandal M. By Cytokine and Growth Factor Reviews 52 68-75 (2020)
Book Chapter/Section
• Causes of Cancer: physical, Chemical, biological Carcinogenesis, and viruses Das S., Kundu M. , Jena B. C., Mandal M. By Biomaterials for 3D Tumor Modeling 607-641 (2020)
• The Interplay of Autophagy and the Immune System in the Tumor Microenvironment Das C. K., Jena B. C., Majumder R. , Panda H. T., Mandal M. By Autophagy in tumor and tumor microenvironment 183-202 (2020)
• Therapeutic aspects of heat shock proteins in glioma: Cementing the crevasses between bench and bedside( In press) Rajesh Y., Kumar U. , Mandal M. By Heat Shock Proteins in Neuroscience, - (2019)
• Regulation of extracellular matrix remodeling and epithelial-mesenchymal transition by matrix metalloproteinases: decisive candidates in tumor progression Rajesh Y., Mandal M. By Proteases in Physiology and Pathology 159-154 (2017)
• Liposomes as a drug delivery system Banerjee K., Banerjee S. , Mandal M. By Biological and Pharmaceutical Applications of Nanomaterials. Liposomes as a drug delivery system - (2015)
• Mechanism of Controlling Blood Vessel Growth and Development and Identification of Therapeutics Against Pathological Angiogenesis Parida S., Mandal M. By Anti-Angiogenesis Drug Discovery and Development 3-62 (2014)
• Anti cancer Activity of Honey and its Phenolic components Kumar S., Mandal M. By Anti cancer Activity of Honey and its Phenolic components - (2011)
• Breast Cancer: Classification Based on Molecular Etiology Influencing Prognosis and Prediction Sarkar S., Mandal M. By Breast Cancer: Classification Based on Molecular Etiology Influencing Prognosis and Prediction 69-84 (2011)
• A Novel Sperm Motility-promoting Protein from Blood Serum and Its Applied Potential Majumder G. C., Mandal M. , Banerjee S. By In Recent Advances in Animal Science Research 61-67 (2001)
• Anti-sticking factors and regulators of sperm motility. Majumder G. C., Roy N. , Mandal M. , Banerjee S. By Anti-sticking factors and regulators of sperm motility. 193-210 (1992)
Congress
• Silk sericin based hydrogel and nanofibrous matrices for skin regeneration Sapru S., Das S. , Mandal M. , Kundu S. C., Ghosh A. K. By TERMIS-AP + ABMC7 2019 Congress - (2019)
Conferences
• Integrin 1 regulates doxorubicin resistance in breast cancer via FAK-mediated activation of ERK1 pathway Das S., Jena B. C., Mundre S. , Parekh A. , Rajesh Y. , Mandal M. By Annual meeting of American Association of Cancer Research 4022-4022 (2018)
• Parkin-mediated mitophagy regulates 5-fluorouracil-induced chemoresistance in breast cancer Das C. K., Jena B. C., Das S. , Parekh A. , Dey G. , Bharti R. , Bharadwaj D. , Mandal M. By AACR Annual Conference 2018 at Chicago, USA 1348-1348 (2018)
• Tamoxifen resistance breast cancer induces mesenchymal phenotype in fibroblasts through TGF 1 signalling Jena B. C., Das C. K., Bharadwaj, D. , Das S. , Parekh A. , Mandal M. By European Congress on Biotechnology - (2018)
• Targeting ECM via stress associated regulation: A potential therapeutic avenue for overcoming temozolamide resistance in glioblastoma Biswas A., Yetirajam R. , Das S. , Parekh A. , Mandal M. By European Congress on Biotechnology - (2018)
• Polyploid giant cancer cells induce growth arrest and cytoskeletal rearrangement in breast cancer cells Bharadwaj, D., Parekh A. , Das S. , Jena B. C., Mandal M. By European Congress on Biotechnology - (2018)
• Antibacterial nanofibrous matrices of non-mulberry silk sericin for wound repair Sapru S., Mandal M. , Ghosh A. K., Kundu S. C. By TERMIS-AM Annual conference and Exhibition - (2016)
• Non-mulberry silk fibroin based nerve guide biomaterials for neural tissue engineering Naskar D., Sapru S. , Li Z. , Yang X. , Mandal M. , Ghosh A. K., Kundu S. C. By European chapter meeting TERMIS, Upsala, Sweden - (2016)
• AFM based Biomechanical Characterization for Assessment of Cancer Aggressiveness Das D., Anura A. , Das S. , Mandal M. , Das S. By Biophysical Society Conference: Mechanobiology of Disease - (2016)
Patent
• System for cytoreduction of circulating cancer cells from blood and a method thereof: Chhatrala P., Parida S. , Mandal M. By - (2015)
• A lipopeptide isolated from a marine bacterium for breast cancer therapy Sen R., Mandal M. , E. By - (2013)
• Anti Bacterial Hydrogel Composition and Application Thereof Mandal S. M., Mandal M. By - (2013)
• A process for the purification of a new motility-promoting protein from buffalo serum: A slaughter house waste Majumder G. C., Mandal M. , Banerjee S. By - (1997)
• A process for the purification of a new motility-promoting protein from buffalo serum: A slaughter house waste Majumder G. C., Mandal M. , Banerjee S. By - (1997)

Principal Investigator

• DETERMINING THE MECHANISMS OF S100A7 (PSORIASIN) IN MEDIATING ANOIKIS RESTANCE AND TUMOR PROGRESSION IN SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY
• EVALUATION OF S100A7 (PSORIASIN) AS AN EARLY DETEDTION MARKER OF CELL CARCINOMA
• INDIAN ORIGIN SILK BASED BIOMIMETIC SCAFFOLDS FOR ENGINEERING OF LOAD BEARING TISSUE
• SEQUENCE DEPENDENT MOLECULAR ACTION OF ZD6474 WITH PACLITAXEL AND RADIATION IN PROGRESSION AND TREATMENT OF BREAST CANCER.
• Involvement of functional single nucleotide polymorphisms (SNP) of matrix metalloproteinase (MMP) gene promoters in the cell type specific regulation of human MMPs: intrinsic genetic characteristics in cancer cell progression
• Unraveling cancer transformation and progression through biological, electro-mechanical and computational techniques
• Natural silk protein based modification of Orthopedic implant to improve osteogenesis and osseo-integration
• Delivery of drugs and cells to the cornea using silk protein-A novel therapeutic approach
• Engineered silk matrices for optimization of in vitro 3 D tumour model
• Dealing with the cancer of Cervix: Enhancing the efficacy of ionizing radiation with gold nanoparticle
• Combining Metformin and Metronomic Liposomal Chemotherapeutic Formulation for Effective Management of Multiple Cancers
• Pilot Scale Study on Local Inhabitants Reduction of Fear to AAI Programme as Par Demand of Local Administration
• System for Cyto - Reduction of Circulating Cancer Cells from Blood and a Method Thereof
• Evaluation of Resveratrol Loaded Nanoparticle on Apoptosis in Oral Cancer Stem Cell by Crosstalking through Hedgehog-Gil and WNT-TCF Cascade
• Designer Therapeutic Elucidation of Novel Small Molecular Inhibitor Targeting ETV6-NTRK3 Associated Gene Fusion in Glioblastoma
• Nano-platform Based Carboplatin Delivery in Retinoblastoma by Modulating Blood Retinal Barrier

Co-Principal Investigator

• Customized Bioactive Porous Titanium Implants with Improved Tissue-integration and Attenuated Aseptic Loosening for Orthopaedic Applications
• Development of a CUDA C/C++ based Whole-cell Simulator Package
• Development of dense and porous Titanium components via powder metallurgy route for biomedical applications
• ENHANCED PRODUCTION, PURIFICATION AND CHARACTERIZATION OF MARINE BACTERIAL LIPOPEPTIDE AS POTENTIAL BROAD-SPECTRUM ANTIMICROBIAL AND ANTICANCER AGENT FOR BREAST CANCER THERAPY
• Photoresponsive Nanoconjugates for Efficient Combination Chemotherapy : Sequential and Cocktail Approaches
• Signals & systems for life science
• STUDY OF EXTRACELLULAR FIBRILLAR BIOPOLYMERS NATURAL SILK FIBRES SILK PROTEIN SCAFFOLDS AND PROTEOGLYCAN FIBRIL OF BOTH MUCUS AND EXTRACELLULAR MATRIX TISSUE
• Synthesis, Solution Properties and In Vitro Evaluation of Stimuli-Responsive Polymer-Based Prodrug Systems